Supriya Lifescience Limited (NSE:SUPRIYA)
India · Delayed Price · Currency is INR 865.50
+5.60 (0.65%)
Jul 31, 2026, 3:29 PM IST
Supriya Lifescience Market Cap
Supriya Lifescience has a market cap or net worth of 69.78 billion as of July 31, 2026. Its market cap has increased by 29.78% in one year.
Market Cap
69.78B
Enterprise Value
69.04B
Revenue
8.28B
Ranking
n/a
PE Ratio
33.37
Stock Price
865.50
ChartMarket Cap Chart
Since December 28, 2021, Supriya Lifescience's market cap has increased from 31.46B to 69.78B, an increase of 121.82%. That is a compound annual growth rate of 18.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 69.78B | 15.37% |
| Dec 31, 2025 | 60.48B | 1.58% |
| Dec 31, 2024 | 59.54B | 135.04% |
| Dec 29, 2023 | 25.33B | 33.91% |
| Dec 30, 2022 | 18.92B | -51.41% |
| Dec 31, 2021 | 38.93B | 23.76% |
| Dec 28, 2021 | 31.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 689.42B |
| Anthem Biosciences | 455.74B |
| OneSource Specialty Pharma | 185.69B |
| Concord Biotech | 148.64B |
| Blue Jet Healthcare | 118.53B |
| Zota Health Care | 44.31B |
| Dishman Carbogen Amcis | 29.31B |
| Panacea Biotec | 25.81B |